AU Patent

AU2013305930B2 — Haptens of paliperidone

Assigned to Saladax Biomedical Inc · Expires 2017-08-24 · 9y expired

What this patent protects

The invention relates to compounds of Formula (I), wherein L

USPTO Abstract

The invention relates to compounds of Formula (I), wherein L

Drugs covered by this patent

zoliflodacin (ZOLIFLODACIN)

Patent Metadata

Patent number: AU2013305930B2
Jurisdiction: AU
Classification: —
Expires: 2017-08-24
Drug substance claim: No
Drug product claim: No
Assignee: Saladax Biomedical Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.